Scalp and Intracranial EEG-fMRI in Epilepsy

Louis André Van Graan, Louis Lemieux and Umair Javaid Chaudhary

The choice of treatment for epilepsy patients relies on the identification and characterization of epileptic discharges and the type of epilepsy. The continued lack of a univers..Voir plus»

Medicinal and Pharmaceutical Research through Open Innovation

Isla Horvath

Over the past ten years, open innovation has progressively increased in the fields of medicine and pharmaceutical research. However, there hasn't been much research done on ..Voir plus»

Photoperiod Influences the Effects of Ghrelin and Serotonin Receptor Agonist on Growth Hormone and Prolactin Secretion in Sheep

Dorota A Zieba, Katarzyna Kirsz, Malgorzata Szczesna, Edyta Molik, Katarzyna Romanowicz and Tomasz Misztal

Objective: Recent studies have identified a novel heterodimer involving the ghrelin receptor (GHS-R1A) and the
5-HT2C receptor, a subtype of serotonin receptors. Whether ..Voir plus»

Characteristics of an at-risk patient population presenting to a Philadelphia student-run free clinic within 30 days of hospital visit

Kaitlyn Thomesen

Background

Day-30 readmission rates are the parameter that hospitals and insurance companies use to measure clinical quality of care and set reimburse..Voir plus»

Review on Recent Advances in Multiple Sclerosis and Related Disorders

Silvia N. Tenembaum and Garrahan JP

The scientific world of central nervous system (CNS) neuroinflammatory disorders in general and multiple
sclerosis (MS) in particular continues to expand, and 2013 has wi..Voir plus»

Natalizumab Associated PML in a Multiple Sclerosis Patient: Excellent Response to Minimal Intervention

Silvia R. Delgado, Efrat Saraf Lavi, Yesica A. Campos, Melissa Ortega, Kottil Rammohan, William A. Sheremata

We present a case of a woman with natalizumab associated progressive multifocal leukoencephalopathy (PML) who developed an immune reconstitution inflammatory syndrome (IRIS) 9 w..Voir plus»